Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00071448 · ClinicalTrials.gov registry record · Phase 3
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
A Phase 3 study, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- Phase 3
- Development phase
- 378
- Enrollment target
NCT00071448 is a Phase 3 study that has completed, run by Novo Nordisk A/S. The registered enrollment target is 378 participants.
The verdict
NCT00071448, a Phase 3 study, has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 378 participants
- Enrollment target
Study Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to to determine whether insulin aspart can be used effectively and safely in paediatric patients.
Interventions
- DRUG insulin aspart
- DRUG insulin lispro
- DRUG insulin human
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 378 participants |
| Start Date | 2002-06 |
| Est. Completion | 2004-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00071448
The ClinicalTrials.gov registry entry for NCT00071448 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 378 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which insulin aspart is the first listed.
NCT00071448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00071448 about?
NCT00071448 is a clinical study titled "Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population". This trial is conducted in the United States of America (USA). The aim of this trial is to to determine whether insulin aspart can be used effectively and safely in paediatric patients.
What is the current status of trial NCT00071448?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 378 participants. The study started on 2002-06. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00071448?
The interventions under investigation include: insulin aspart (DRUG), insulin lispro (DRUG), insulin human (DRUG).
Who is sponsoring clinical trial NCT00071448?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.